Probiomed SA de CV - Company Review
Probiomed SA de CV - Company ReviewSummary
Probiomed SA de CV (Probiomed), a subsidiary of Proquifin SA de CV is a biopharmaceutical company that offers research, development, manufacture and marketing of pharmaceutics and biotechnology products. The company’s provides pharmaceuticals and genetically engineered recombinant proteins. Its products find applications in the areas of internal medicine, family medicine, cardiology, nephrology, endocrinology, neurology, ENT, oncology gynecology, psychiatry, orthopedics, and hematology. Probiomed also offers treatment alternatives and also monitors safety of its drugs through its pharmacovigilence program. The company exports both active pharmaceutical ingredients and finished drugs through a network of distributors across the world. It operates through its offices in Azcapotzalco, Tenancingo, Iztapalapa and Ciudad Juarez, Mexico. Probiomed is headquartered in Mexico City, Mexico.
This comprehensive company report of Probiomed SA de CV provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.